Drug application
PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER (DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE and 3 more)
Drugs@FDA NDA 017451 · BAXTER HLTHCARE
Key facts
| Drug name | PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE, SODIUM CHLORIDE, SODIUM GLUCONATE |
| Application type | NDA |
| Application number | 017451 |
| Company | BAXTER HLTHCARE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 5GM/100ML;30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Feb 2, 1979 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: